97 related articles for article (PubMed ID: 17574849)
1. Inhibitors of anthrax lethal factor.
Gaddis BD; Avramova LV; Chmielewski J
Bioorg Med Chem Lett; 2007 Aug; 17(16):4575-8. PubMed ID: 17574849
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
Gaddis BD; Rubert Pérez CM; Chmielewski J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2467-70. PubMed ID: 18314330
[TBL] [Abstract][Full Text] [Related]
3. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
[TBL] [Abstract][Full Text] [Related]
4. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.
Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Tang W; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Salowe SP; Zaller DM; Scolnick EM; Schmatz DM; Bartizal K; Hermes JD; MacCoss M; Chapman KT
Bioorg Med Chem Lett; 2006 Feb; 16(4):964-8. PubMed ID: 16338135
[TBL] [Abstract][Full Text] [Related]
5. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
[TBL] [Abstract][Full Text] [Related]
7. Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.
Roy J; Kumar UC; Machiraju PK; Muttineni RK; Kumar B V S S; Gundla R; Dayam R; Sarma JA
J Mol Graph Model; 2010 Sep; 29(2):256-65. PubMed ID: 20727800
[TBL] [Abstract][Full Text] [Related]
8. Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin.
Karginov VA; Yohannes A; Robinson TM; Fahmi NE; Alibek K; Hecht SM
Bioorg Med Chem; 2006 Jan; 14(1):33-40. PubMed ID: 16169738
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic differences between in vitro assays for hydrazone-based small molecule inhibitors of anthrax lethal factor.
Hanna ML; Tarasow TM; Perkins J
Bioorg Chem; 2007 Feb; 35(1):50-8. PubMed ID: 16949126
[TBL] [Abstract][Full Text] [Related]
10. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
Thomas M; Castignetti D
J Microbiol Immunol Infect; 2009 Aug; 42(4):284-9. PubMed ID: 19949750
[TBL] [Abstract][Full Text] [Related]
11. Rhodanine derivatives as selective protease inhibitors against bacterial toxins.
Johnson SL; Chen LH; Harbach R; Sabet M; Savinov A; Cotton NJ; Strongin A; Guiney D; Pellecchia M
Chem Biol Drug Des; 2008 Feb; 71(2):131-9. PubMed ID: 18221310
[TBL] [Abstract][Full Text] [Related]
12. Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitor.
Kong Y; Guo Q; Yu C; Dong D; Zhao J; Cai C; Hou L; Song X; Fu L; Xu J; Chen W
FEBS Lett; 2009 Apr; 583(8):1257-60. PubMed ID: 19332063
[TBL] [Abstract][Full Text] [Related]
13. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
Jiao GS; Cregar L; Goldman ME; Millis SZ; Tang C
Bioorg Med Chem Lett; 2006 Mar; 16(6):1527-31. PubMed ID: 16386899
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
Gujraty KV; Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
Biomacromolecules; 2006 Jul; 7(7):2082-5. PubMed ID: 16827573
[TBL] [Abstract][Full Text] [Related]
15. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.
Montecucco C; Tonello F; Zanotti G
Trends Biochem Sci; 2004 Jun; 29(6):282-5. PubMed ID: 15276179
[TBL] [Abstract][Full Text] [Related]
16. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
Jiao GS; Simo O; Nagata M; O'Malley S; Hemscheidt T; Cregar L; Millis SZ; Goldman ME; Tang C
Bioorg Med Chem Lett; 2006 Oct; 16(19):5183-9. PubMed ID: 16870442
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel anthrax lethal factor inhibitors generated by combinatorial Pictet-Spengler reaction followed by screening in situ.
Numa MM; Lee LV; Hsu CC; Bower KE; Wong CH
Chembiochem; 2005 Jun; 6(6):1002-6. PubMed ID: 15880659
[No Abstract] [Full Text] [Related]
18. D-proline-based peptidomimetic inhibitors of anthrax lethal factor.
Calugi C; Trabocchi A; Lalli C; Guarna A
Eur J Med Chem; 2012 Oct; 56():96-107. PubMed ID: 22960696
[TBL] [Abstract][Full Text] [Related]
19. Identification of toxin inhibitors using a magnetic nanosensor-based assay.
Santiesteban OJ; Kaittanis C; Perez JM
Small; 2014 Mar; 10(6):1202-11. PubMed ID: 24339142
[TBL] [Abstract][Full Text] [Related]
20. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.
Johnson SL; Jung D; Forino M; Chen Y; Satterthwait A; Rozanov DV; Strongin AY; Pellecchia M
J Med Chem; 2006 Jan; 49(1):27-30. PubMed ID: 16392787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
